Arrowhead Pharmaceuticals | 4:持股變動聲明-董事 Vakiener Victoria
Arrowhead Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(10.01%)
Arrowhead Pharmaceuticals | 4:持股變動聲明-高管 Hamilton James C
Arrowhead Pharmaceuticals | 4:持股變動聲明-董事 Lu Hongbo
Arrowhead Pharmaceuticals | 3:首次持股聲明-董事 Lu Hongbo
Arrowhead Pharmaceuticals | 4:持股變動聲明-高管 Myszkowski Kenneth Allen
Arrowhead Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(9.93%)
Arrowhead Pharmaceuticals | 4:持股變動聲明-高管 Anzalone Christopher Richard
Arrowhead Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-STATE STREET CORPORATION(6.35%)
Arrowhead Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(12.4%)
Arrowhead Pharmaceuticals | 4:持股變動聲明-高管 Hamilton James C
Arrowhead Pharmaceuticals | 4:持股變動聲明-董事 GIVEN DOUGLAS B
Arrowhead Pharmaceuticals | 4:持股變動聲明-董事 Waddill William D.
Arrowhead Pharmaceuticals | 4:持股變動聲明-董事 Ferrari Mauro
Arrowhead Pharmaceuticals | 4:持股變動聲明-董事 Vakiener Victoria
Arrowhead Pharmaceuticals | 4:持股變動聲明-高管 Oliver Tracie
Arrowhead Pharmaceuticals | 4:持股變動聲明-高管 Myszkowski Kenneth Allen
Arrowhead Pharmaceuticals | 4:持股變動聲明-高管 San Martin Javier
Arrowhead Pharmaceuticals | 4:持股變動聲明- Hamilton James C
Arrowhead Pharmaceuticals | 4:持股變動聲明-高管 O'Brien Patrick
暫無數據